Condensed Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022	[1]
Current assets
Cash and cash equivalents	$ 57,679	$ 33,685
Short-term investments	465,933	297,502
Accounts receivable	0	1,983
Tax credit receivable	83	83
Prepaid expenses and other current assets (Note 5)	10,640	7,058
Total current assets	534,335	340,311
Property and equipment, net	3,969	4,486
Operating lease right-of-use assets	1,768	5,422
Other non-current assets	392	394
Total assets	540,464	350,613
Current liabilities
Accounts payable	3,360	1,580
Accrued research and development	13,664	11,218
Accrued liabilities (Note 6)	8,310	8,658
Lease liabilities, current	2,061	2,457
Total current liabilities	27,395	23,913
Lease liabilities, non-current	0	3,429
Long-term debt (Note 7)	10,021	9,929
Total liabilities	37,416	37,271
Stockholders’ equity
Common stock, $0.0001 par value; 300,000,000 shares authorized at September 30, 2023 and December 31, 2022; and 59,890,980 and 48,941,254 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively;	6	5
Additional paid-in capital	963,588	653,707
Accumulated deficit	(458,639)	(338,412)
Accumulated other comprehensive loss	(1,907)	(1,958)
Total stockholders’ equity	503,048	313,342
Total liabilities and stockholders’ equity	$ 540,464	$ 350,613

[1] The condensed balance sheet as of December 31, 2022 has been derived from the audited financial statements as of that date.